Microfluidic Advancements in Simultaneous Detection of Infectious Pathogens

Maria Razak^*
*Correspondence: Maria Razak, Department of Microbiology, Poznan University of Technology, Berdychowo 4, PL-60965 Poznan, Poland, Email:

Introduction

Infectious diseases are brought about by microorganisms, including infections, microbes and parasites. As one of the best dangers to human wellbeing and worldwide security, Infectious diseases contribute the most to the worldwide sickness trouble. Touchy and exact screening strategies are the absolute best method for recognizing wellsprings of disease and controlling infectivity. Microfluidic platforms have revolutionized the field of infectious disease diagnostics by offering rapid, efficient and multiplexed detection capabilities [1]. Infectious diseases continue to pose significant global health challenges, demanding accurate and timely diagnostic methods for effective management and control. Traditional diagnostic approaches often suffer from limitations such as lengthy processing times, complex procedures and limited multiplexing abilities. In response, microfluidic advancements have emerged as a promising solution, enabling the simultaneous detection of multiple infectious pathogens with enhanced sensitivity and specificity. This paper delves into the innovative applications and benefits of microfluidic technology in the realm of infectious disease detection, highlighting its potential to reshape diagnostic strategies and ultimately improve public health outcomes [2].

Description

Microfluidic platforms capitalize on precise manipulation of small fluid volumes within microscale channels, resulting in accelerated reaction kinetics and reduced reagent consumption. These platforms integrate various functions such as sample preparation, amplification and detection into compact and automated systems. One of the key advantages lies in their ability to perform multiplexed assays, where multiple pathogenic targets can be detected in a single assay, expediting the diagnostic process and conserving valuable resources [3]. This advancement is particularly significant in scenarios where rapid identification of co-circulating pathogens is crucial, as seen in outbreaks or co-infection cases. Microfluidic devices can incorporate diverse detection modalities including nucleic acid amplification techniques (PCR, RT-qPCR, LAMP), immunoassays (ELISA, lateral flow) and biosensors (optical, electrochemical). These technologies enhance sensitivity and enable real-time monitoring of pathogen-specific biomarkers. Moreover, microfluidic systems offer precise control over reaction conditions, leading to reduced false-positive and false-negative results. The integration of these technologies with microfluidic platforms optimizes the entire diagnostic workflow, from sample collection and processing to data analysis [4,5].

Conclusion

Microfluidic advancements have ushered in a new era of infectious disease detection by overcoming the limitations of traditional diagnostic methods. The ability to simultaneously detect multiple infectious pathogens with enhanced speed, sensitivity and specificity holds immense promise for improving patient care, outbreak management and epidemiological surveillance. However, despite the remarkable progress, challenges such as standardization, scalability and accessibility must be addressed for the widespread adoption of microfluidic-based diagnostics. As research and development in this field continue, collaboration between scientists, engineers and healthcare professionals will be essential to ensure the successful translation of these technologies from the laboratory to the clinical setting. Ultimately, microfluidic platforms have the potential to redefine the landscape of infectious disease diagnostics, offering a brighter future for global health.

Acknowledgement

None

Conflict of Interest

There are no conflicts of interest by author.

References

1. Wang, Xin, Xian-Zhe Hong, Yi-Wei Li and Ying Li, et al. "Microfluidics-based strategies for molecular diagnostics of infectious diseases." Mil Med Res 9 (2022): 1-27.

Google Scholar, Crossref, Indexed at

2. Ackerman, Cheri M., Cameron Myhrvold, Sri Gowtham Thakku and Catherine A. Freije, et al. "Massively multiplexed nucleic acid detection with Cas13." Nature 582 (2020): 277-282.

Google Scholar, Crossref, Indexed at

3. Zhang, Xiao-Xi, Jing-Shu Liu, Le-Fei Han and Shang Xia, et al. "Towards a global One Health index: A potential assessment tool for One Health performance." Infect Dis Poverty 11 (2022): 12-26.

Google Scholar, Crossref, Indexed at

4. Wang, Chao, Mei Liu, Zhifei Wang and Song Li, et al. "Point-of-care diagnostics for infectious diseases: From methods to devices." Nano Today 37 (2021): 101092.

Google Scholar, Crossref, Indexed at

5. Zhang, Haoqing, Ying Xu, Zdenka Fohlerova and Honglong Chang, et al. "LAMP-on-a-chip: Revising microfluidic platforms for loop-mediated DNA amplification." TrAC Trends Anal Chem 113 (2019): 44-53.

Google Scholar, Crossref, Indexed at